Our sales and marketing team has commercialized all of our FDA approved brands.

A second component of our growth strategy is to acquire approved brands that serve patient populations that our sales and marketing team can effectively reach. We seek proprietary products that provide a differentiated benefit to patients. In addition, we target products that could benefit from the promotional capabilities of our sales and marketing organization or that could be expanded to help new patient groups through the efforts of our development team.

Where appropriate, Cumberland is poised to acquire and negotiate rights to those products to support and commercialize them. In acquiring these already approved products, we are able to add to our growing portfolio to meet the needs of patients. Our strong balance sheet and cash flow provide the financial resources to support these acquisition efforts.